Encora Therapeutics
Daniel Carballo is the CEO of Encora Therapeutics, a venture-backed neurotech startup that received the FDA Breakthrough Device Designation. Daniel has a background in mechanical engineering and has worked on various research projects related to robotics at MIT, Apple, NASA JPL, and more. Daniel has also been recognized with awards such as the MassMedic IGNITE 2021 First Place Winner and the BostInno 25U25.
This person is not in any teams
Encora Therapeutics
We’re 4 MIT engineers who started Encora to research wearable solutions for patients with movement disorders. We’re leveraging advances in wearable technology, signal processing, reinforcement learning, and patient sensing to provide affordable, personalized, non-invasive remedies for patients with neurological movement disorders. As part of the PD community, we're also raising awareness for #parkinsons!